ANKRD5 Inhibitors
Chemical inhibitors of ANKRD5 target specific signaling pathways and enzymatic activities to achieve functional inhibition of the protein. H-89, as an inhibitor of protein kinase A (PKA), can impede the phosphorylation of ANKRD5. Similarly, LY294002 disrupts the phosphatidylinositol 3-kinase (PI3K) pathway, which could lead to reduced ANKRD5 activity. SB203580 and PD98059, which inhibit p38 MAP kinase and MEK respectively, can impede the activation of ANKRD5. The mTOR pathway, which can be inhibited by Rapamycin, may also play a critical role in regulating ANKRD5, leading to its functional inhibition.
Further inhibition strategies include the use of KN-93, an inhibitor of CaMKII, which can block the activity of ANKRD5. PP2, acting as an Src family kinase inhibitor, can suppress the activity of ANKRD5. The JNK pathway, targeted by SP600125, may also control ANKRD5 activity, with inhibition of JNK leading to decreased ANKRD5 function. Y-27632 inhibits Rho-associated protein kinase (ROCK), which could also impact ANKRD5. Bortezomib, a proteasome inhibitor, could lead to the accumulation of specific regulatory proteins that modulate ANKRD5 activity, resulting in its inhibition. Additionally, Go6983 and U73122, which inhibit protein kinase C (PKC) and phospholipase C (PLC) respectively, can functionally inhibit ANKRD5. Each of these chemicals acts upon a specific molecular target or pathway to inhibit the function of ANKRD5 through distinct biochemical mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphatidylinositol 3-kinase (PI3K) inhibitor. Should ANKRD5 activity be PI3K pathway-dependent, LY294002 can lead to a reduction in ANKRD5 activity by disrupting downstream signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor. If ANKRD5 is activated downstream of the p38 MAPK pathway, SB203580 can prevent its activation, resulting in functional inhibition of ANKRD5. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which functions in the MAPK/ERK pathway. If ANKRD5 operates downstream of this pathway, then PD98059 can inhibit MEK and subsequently inhibit ANKRD5 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. If ANKRD5 is part of the PI3K/AKT/mTOR pathway, Rapamycin can inhibit this pathway and lead to ANKRD5 inhibition. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is an inhibitor of CaMKII. If ANKRD5 is activated by CaMKII, then KN-93 can inhibit this kinase, resulting in the functional inhibition of ANKRD5. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. If ANKRD5 relies on Src kinase signaling for its function, PP2 can inhibit these kinases and thus inhibit ANKRD5 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). If ANKRD5 activity is modulated through the JNK pathway, inhibition by SP600125 would lead to the functional inhibition of ANKRD5. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a Rho-associated protein kinase (ROCK) inhibitor. If ANKRD5 activity involves signaling through the ROCK pathway, Y-27632 can inhibit this pathway and functionally inhibit ANKRD5. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor. If ANKRD5 is regulated by proteasomal degradation of its activators or inhibitors, Bortezomib’s action can lead to altered levels of these proteins and thereby inhibit ANKRD5 function. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go6983 is a protein kinase C (PKC) inhibitor. If ANKRD5 is activated by PKC-dependent phosphorylation, Go6983 can inhibit PKC and thus lead to functional inhibition of ANKRD5. | ||||||